Go to content
UR Home

Diabetes, use of metformin, and the risk of meningioma

URN to cite this document:
DOI to cite this document:
Leitzmann, Michael F. ; Seliger, Corinna ; Meier, Christoph R. ; Becker, Claudia ; Jick, Susan S. ; Proescholdt, Martin ; Bogdahn, Ulrich ; Hau, Peter
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 19 Jan 2018 11:20


Background Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. Methods We conducted a matched case-control analysis using data from the U. K.-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons